Inhibikase Therapeutics, Inc. today announced that the first patient has been dosed in its Phase 2 ‘201’ trial evaluating IkT-148009, the Company’s novel Abelson Tyrosine Kinase, or c-Abl, inhibitor for the treatment of Parkinson’s disease.
Soligenix, Inc. announced today that the European Patent Office has granted a patent entitled “Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis”.
Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis Read More »
Aviceda Therapeutics today announced the appointment of Patrick Johnson to its board of directors.
NanoViricides, Inc., reports that it has filed its Quarterly Report on Form 10-Q for the fiscal third quarter ending March 31, 2023 with the Securities and Exchange Commission on Monday, May 15, 2023.
Caris Life Sciences® announced that Robert H. Lurie Comprehensive Cancer Center of Northwestern University has joined the Caris Precision Oncology Alliance™.
BD (Becton, Dickinson and Company) today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new BD Kiestra™ Methicillin-resistant Staphylococcus aureus (MRSA) imaging application that uses artificial intelligence (AI) to interpret bacterial growth and release negative specimens with minimal human interaction.
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics Read More »
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced its financial results for the first quarter of 2023 and provided a business update.
Durante los últimos años se vio una notable evolución en aparatos eléctricos relacionados con la cocina, ya que salieron a la venta artículos sumamente interesantes, con una funcionalidad única que le permite a cualquier integrante de una casa pode …
Las freidoras de aire, un invento que cuida las vidas de las personas Read More »
Sony Corporation and Astellas Pharma Inc. announced that they have entered into a collaborative research agreement to discover a novel Antibody-Drug Conjugate platform in oncology based on Sony’s unique polymeric material, “KIRAVIA™ Backbone.”
AlzeCure Pharma AB announced that the company is participating at Penser Market on May 25 at 14:05 CET, where CEO Martin Jönsson will present and answer questions about the latest development in the company.
AlzeCure Participates at Penser Market on May 25 Read More »
